165 related articles for article (PubMed ID: 7318191)
21. Human chorionic gonadotropin and thyroid function in patients with hydatidiform mole.
Amir SM; Osathanondh R; Berkowitz RS; Goldstein DP
Am J Obstet Gynecol; 1984 Nov; 150(6):723-8. PubMed ID: 6496594
[TBL] [Abstract][Full Text] [Related]
22. Thyroid function in molar pregnancy.
Nagataki S; Mizuno M; Sakamoto S; Irie M; Shizume K
J Clin Endocrinol Metab; 1977 Feb; 44(2):254-63. PubMed ID: 402378
[TBL] [Abstract][Full Text] [Related]
23. Choriocarcinoma as a cause of thyrotoxicosis.
Morley JE; Jacobson RJ; Melamed J; Hershman JM
Am J Med; 1976 Jun; 60(7):1036-40. PubMed ID: 945690
[TBL] [Abstract][Full Text] [Related]
24. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
Zhang WY; Yen GL
Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
[TBL] [Abstract][Full Text] [Related]
25. Incomplete mole with a false-low level of human chorionic gonadotropin and hyperthyroidism.
Henriksen R; Opheim GL; Saltrøe E
Acta Obstet Gynecol Scand; 2007; 86(5):633-5. PubMed ID: 17464597
[No Abstract] [Full Text] [Related]
26. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
[TBL] [Abstract][Full Text] [Related]
27. Serum progesterone and serum chorionic gonadotrophin in hydatidiform mole and choriocarcinoma.
Teoh ES; Das NP; Dawood MY; Ratnam SS
Acta Endocrinol (Copenh); 1972 Aug; 70(4):791-800. PubMed ID: 5068403
[No Abstract] [Full Text] [Related]
28. Choriocarcinoma following ovarian hydatidiform mole: a case report.
Joneborg U; Papadogiannakis N; Lindell G; Marions L
J Reprod Med; 2011; 56(11-12):511-4. PubMed ID: 22195336
[TBL] [Abstract][Full Text] [Related]
29. Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review.
Braga A; Maestá I; Short D; Savage P; Harvey R; Seckl MJ
BJOG; 2016 Jul; 123(8):1330-5. PubMed ID: 26444183
[TBL] [Abstract][Full Text] [Related]
30. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
Fan C; Goto S; Furuhashi Y; Tomoda Y
J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
[TBL] [Abstract][Full Text] [Related]
31. [Radioimmunoassay of beta sub unit HCG following hydatidiform mole or chorionic carcinoma (author's transl)].
Tscherne G; Pürstner P
Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):704-8. PubMed ID: 478273
[TBL] [Abstract][Full Text] [Related]
32. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
Kim BW; Cho H; Kim H; Nam EJ; Kim SW; Kim S; Kim YT; Kim JH
Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
[TBL] [Abstract][Full Text] [Related]
33. [Hyperthyroidism in molar pregnancy].
Boufettal H; Mahdoui S; Noun M; Hermas S; Samouh N
Rev Med Interne; 2014 Mar; 35(3):202-5. PubMed ID: 24074966
[TBL] [Abstract][Full Text] [Related]
34. Gestational choriocarcinoma and thyrotoxicosis.
Anderson NR; Lokich JJ; McDermott WV; Trey C; Falchuk KR
Cancer; 1979 Jul; 44(1):304-6. PubMed ID: 455255
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
Takayama M; Soma H; Isaka K; Okudera K; Ogawa T; Kikuchi K
Gynecol Obstet Invest; 1987; 23(3):151-6. PubMed ID: 3036671
[TBL] [Abstract][Full Text] [Related]
36. [HCG in patients with hydatidiform mole or chorionepithelioma].
Rjosk HK; Gokel JM; Holzmann K
Arch Gynecol; 1979 Jul; 228(1-4):667-8. PubMed ID: 485551
[No Abstract] [Full Text] [Related]
37. Choriocarcinoma associated with thyrotoxicosis: a case report.
Haram K; Klykken B; Engebjerg E
Int J Gynaecol Obstet; 1979; 17(3):206-8. PubMed ID: 42570
[TBL] [Abstract][Full Text] [Related]
38. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
Shaarawy M; el-Shobokshy AS; el-Noury AI
Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
[TBL] [Abstract][Full Text] [Related]
39. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
Braga A; Biscaro A; do Amaral Giordani JM; Viggiano M; Elias KM; Berkowitz RS; Seckl MJ
Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
[TBL] [Abstract][Full Text] [Related]
40. Thyroid function in gestational trophoblastic neoplasia: evidence that the thyrotropic activity of chorionic gonadotropin mediates the thyrotoxicosis of choriocarcinoma.
Nisula BC; Taliadouros GS
Am J Obstet Gynecol; 1980 Sep; 138(1):77-85. PubMed ID: 6251724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
